Massimo Pini

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke et al. · New England Journal of Medicine · 2016 · 541 citations · Full text

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke et al. · Journal of Clinical Oncology · 2017 · 238 citations · Full text

Cell Therapy, Immunology, Myeloid Neoplasia +16

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

Alessandro Rambaldi, Anna Grassi, Arianna Masciulli et al. · The Lancet Oncology · 2015 · 176 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +11

Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein

PF di Celle, Antonino Carbone, Dan Zhou et al. · Blood · 1994 · 114 citations · Full text